ShangPharma

Activities: Research & Development Pharmaceutical

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  2. Overcoming CMC challenges in cell and gene therapy: part I Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC...
  3. Resolving capping issues in tablet manufacturing Natoli explores the various causes of capping and the methods to prevent it
  4. Effective ways to optimise heat exchangers Heat exchangers are used within a wide range of process industries as a way to transfer heat between two fluid streams across a medium in an energy conservative way
  5. Transforming healthcare with patient centricity In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...

Upcoming event

Cleanroom Conference UK

22–23 May 2024 | Exhibition | Birmingham, UK See all

Related Content

Design & Build

ShangPharma and Qidong Biopharma sign US$60m investment deal in China

Preclinical research facility and a state-of-the-art biologics manufacturing facility to be built in Qidong
Manufacturing

Mitchell Reff becomes Chief Biologics Officer at ShangPharma

He brings more than 30 years of reaearch experience to the position
Manufacturing

ShangPharma appoints Arthur Taveras as President and CSO

Taveras brings the experience of a 24-year career to the Chinese contract research organisation

Buyouts prove popular in China

Chinese pharma companies turning to private capital
You need to be a subscriber to read this article.
Click here to find out more.
Finance

Picking up a good deal

This month Asia correspondent A Nair looks at why the emerging economies provide so many tempting takeover targets for Big Pharma
Research & Development

ShangPharma opens new plant to support Eli Lilly

Also signs a multi-year extension of its contract with the US firm
Subscribe now